We are live on ! Find out more
LPCN icon

Lipocine
LPCN

49 hedge funds and large institutions have $4.16M invested in Lipocine in 2022 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 11 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

5,133% more call options, than puts

Call options by funds: $471K | Put options by funds: $9K

75% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 4

7% more funds holding

Funds holding: 46 → 49 (+3)

0.02% less ownership

Funds ownership: 0.72% → 0.7% (-0.02%)

14% less capital invested

Capital invested by funds: $4.85M → $4.16M (-$694K)

27% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 11

Holders
49
Holders Change
+3
Holders Change %
+6.52%
% of All Funds
0.79%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
8
Reduced
11
Closed
4
Calls
$471K
Puts
$9K
Net Calls
+$462K
Net Calls Change
-$18K

Top Buyers

1
B
Bailard
California
+$35.6K
2
WP
Wealthspan Partners
Iowa
+$31.7K
3
TSS
Two Sigma Securities
New York
+$7.2K
4
UBS Group
UBS Group
Switzerland
+$4.7K
5
TRCT
Tower Research Capital (TRC)
New York
+$4.14K

Top Sellers

1
Citadel Advisors
Citadel Advisors
Florida
-$80.9K
2
VF
Virtu Financial
New York
-$42K
3
Two Sigma Advisers
Two Sigma Advisers
New York
-$20.2K
4
WE
Wealth Effects
Massachusetts
-$15.9K
5
Two Sigma Investments
Two Sigma Investments
New York
-$15.4K
Name Holding Trade Value Shares
Change 		Change in
Stake
AWA
26
Aaron Wealth Advisors
Illinois
$13.8K -$3.9K -535 -20%
MFG
27
Merit Financial Group
Georgia
$11.9K – – –
EWA
28
EP Wealth Advisors
California
$10.2K – – –
Morgan Stanley
29
Morgan Stanley
New York
$9.34K -$5.17K -709 -34%
MSAM
30
Moloney Securities Asset Management
Missouri
$8.95K – – –
TRCT
31
Tower Research Capital (TRC)
New York
$8K +$4.14K +568 +98%
TSS
32
Two Sigma Securities
New York
$6.68K +$7.2K +988 New
Jane Street
33
Jane Street
New York
$6.57K -$6.44K -884 -48%
PMFA
34
Plante Moran Financial Advisors
Michigan
$6.53K – – –
KPWS
35
Kestra Private Wealth Services
Texas
$5.75K – – –
SCA
36
Snowden Capital Advisors
New York
$5K – – –
CG
37
Cutler Group
California
$5K – – –
UBS Group
38
UBS Group
Switzerland
$4.58K +$4.7K +645 +2,224%
Creative Planning
39
Creative Planning
Kansas
$3.98K – – –
Belvedere Trading
40
Belvedere Trading
Illinois
$1.67K +$1.8K +247 New
BFEC
41
Benjamin F. Edwards & Company
Missouri
$1K – – –
JP Morgan Chase
42
JP Morgan Chase
New York
$1K – – –
TC
43
Truvestments Capital
Florida
$560 – – –
Bank of America
44
Bank of America
North Carolina
$475 +$80 +11 +19%
Wells Fargo
45
Wells Fargo
California
$240 – – –
PNC Financial Services Group
46
PNC Financial Services Group
Pennsylvania
$80 +$87 +12 New
NC
47
NewSquare Capital
Pennsylvania
$77 +$87 +12 New
Northwestern Mutual Wealth Management
48
Northwestern Mutual Wealth Management
Wisconsin
$20 +$22 +3 New
VF
49
Virtu Financial
New York
– -$42K -5,495 Closed
Mariner
50
Mariner
Kansas
– -$6K -804 Closed
1
2
3

LPCN Hedge Fund Activity: Q4 2022 in Review

49 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Lipocine (LPCN) for Q4 2022, worth a combined $4.16M — down 14% from $4.85M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new LPCN positions and 4 closed out — a net gain of 3 holders — while 8 added to existing stakes and 11 trimmed.

The largest buyer was Bailard, opening a new position worth an estimated $35.6K. The largest seller was Citadel Advisors, cutting an estimated $80.9K.

  • 49 institutional investors held Lipocine (LPCN) as of Q4 2022, up from 46 in Q3 2022.
  • Funds reported $4.16M of Lipocine stock for Q4 2022, down 14% quarter-over-quarter.
  • 7 funds opened new Lipocine positions in Q4 2022 and 4 closed out, a net change of +3 holders.
  • The largest Lipocine buyer in Q4 2022 was Bailard, an estimated $35.6K added.
  • The largest Lipocine seller in Q4 2022 was Citadel Advisors, an estimated $80.9K sold.

Based on aggregated 13F filings for Q4 2022.